Dave Asprey's Substack

Dave Asprey's Substack

MOTS-c: The Mitochondrial Peptide That Rewrites Exercise Response

Here's what you need to know

Dec 30, 2025
∙ Paid

Your mitochondria don’t just make ATP. In 2015, researchers discovered that mitochondria encode peptides that function as signaling molecules. One of them, MOTS-c (Mitochondrial open reading frame of the 12S ribosomal RNA type-c), does something extraordinary: it mimics the metabolic effects of exercise at the cellular level.

When you exercise, MOTS-c levels spike in your blood and muscle tissue. The peptide activates AMPK (the master metabolic switch that controls how your cells burn fuel), enhances glucose uptake without insulin, improves insulin sensitivity, and triggers the genes that build new mitochondria.

Here’s what matters for longevity: MOTS-c levels decline as you age. Lower MOTS-c correlates with worse metabolic health (higher BMI, waist circumference, fasting insulin, insulin resistance, and HbA1c). The signal your mitochondria send to regulate metabolism weakens over time.

Good news about MOTS-c: you can inject it.

Want the complete protocol?

The paid section covers mechanisms, benefits, exact dosing schedules, sourcing strategies, stacking combinations, and what to monitor.

[Upgrade to paid subscription for full protocols]

User's avatar

Continue reading this post for free, courtesy of Dave Asprey.

Or purchase a paid subscription.
© 2026 Dave Asprey · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture